Start a Conversation
Start a Conversation

Due diligence that goes beyond the data room

Deep, domain-led operational and regulatory diligence for investors and boards across Biopharma, MedTech, Nutritionals, and specialty manufacturing.
Investors and boards require a clear, evidence-based view of quality, regulatory, manufacturing, and supply chain risk - alongside a realistic assessment of scalability and execution capability.
We combine site-level inspection, data interrogation, leadership assessment, and regulatory analysis to answer a single question: is the business truly fit for its growth ambition and investment thesis?

Our Diligence Framework

Quality & Regulatory

  • QMS robustness and CAPA effectiveness
  • Regulatory alignment (FDA, EMA, MHRA, TGA)
  • Data integrity and inspection history

Deliverables:
Regulatory risk heat map, QMS maturity score, red-flag assessment.

Manufacturing & Operations

  • Site assessment and shop-floor observation
  • Yield, deviation, and reliability trends
  • Capacity modelling and CapEx requirements

Deliverables:
Scalability assessment, CapEx exposure, 100-day stabilisation plan.

Supply Chain

  • Inventory exposure and shelf-life risk
  • Supplier concentration and single-point-of-failure mapping
  • Planning maturity and network suitability

Deliverables:
Working capital exposure, mitigation roadmap.

Leadership & Organisation

  • Executive capability and oversight
  • Organisational effectiveness and accountability
  • Performance cadence and governance

Deliverables:
Leadership risk assessment, governance gap analysis.

Typical outputs may include: →

Consolidated red-flag report
Prioritised remediation roadmap
100-day plan aligned to the investment thesis
12 to 24 month value creation plan

Why Clariveer for Diligence

Led by senior leaders who have held direct accountability in regulated environments. We have owned P&L across multi-site networks, led inspections, and managed the same challenges we now assess.

Deliverables are built for Investment Committee and Board use  – clear, defensible, and ready to act on. We operate at transaction pace, with no disconnect between site insight and final conclusions.

Start a Conversation
life-sciences